The PCPT trial

The PCPT trial

Diğer sürümleri göster (2)

The PCPT trial is the first phase III trial with the principal objective of examining the hypothesis that the use of chemoprevention could prevent the development of prostate cancer. This is a large scale randomised clinical trial comparing finasteride (5-α reductase inhibitor) to placebo. A total o...

Detaylı Bibliyografya
Asıl Yazarlar:	Hamdy, F, Rouprêt, M
Materyal Türü:	Journal article
Dil:	French
Baskı/Yayın Bilgisi:	2008

Benzer Materyaller

[The PCPT trial].
Yazar:: Hamdy, F, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

The PCPT trial
Yazar:: Hamdy, F, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Estimating Hydraulic Conductivity of Overconsolidated Soils Based on Piezocone Penetration Test (PCPT)
Yazar:: Binyam M. Bekele, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

In-situ determination of soil compressibility using piezometer cone penetration testing (PCPT)/
Yazar:: 207490 Ismail Bakar, ve diğerleri
Baskı/Yayın Bilgisi: (1981)

Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
Yazar:: Ankerst, D, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

In-situ determination of soil compressibility using piezometer cone penetration testing (PCPT) / [mikrofilem]
Yazar:: 207490 Ismail Bakar

A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort
Yazar:: Samuel Carbunaru, ve diğerleri
Baskı/Yayın Bilgisi: (2019-11-01)

Time-dependent behavior of full-scale precast post-tensioned (PCPT) girders: Experimental and finite element analysis
Yazar:: Panuwat Joyklad, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA
Yazar:: Enrique Gomez Gomez, ve diğerleri
Baskı/Yayın Bilgisi: (2019-11-01)

Correction: Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA
Baskı/Yayın Bilgisi: (2020-02-01)

Prostate cancer risk calculators – PBCG vs. PCPT 2.0: Which one should we use when it comes to clinical decision-making?
Yazar:: A.B. Silva, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

PROSTATE CANCER RISK CALCULATOR COMPARISON: IPCRC vs KPCRC vs PCPT-RC vs ERSPC-RC IN PREDICTING PROSTATE CANCER AT HASAN SADIKIN HOSPITAL
Yazar:: Christiano Tansol, ve diğerleri
Baskı/Yayın Bilgisi: (2017-07-01)

Becoming editor-in-chief of European Urology Oncology: The 4 pillars of the development strategy
Yazar:: M. Rouprêt
Baskı/Yayın Bilgisi: (2023-11-01)

Transurethral resection biopsy as part of a saturation biopsy protocol: a cohort study and review of the literature.
Yazar:: Yates, DR, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
Yazar:: Rouprêt, M, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

The prostate cancer prevention trial and its messages.
Yazar:: Hamdy, F
Baskı/Yayın Bilgisi: (2007)

Clinically localised prostate cancer is microsatellite stable.
Yazar:: Azzouzi, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Word of wisdom. Re: mortality results from the Goteborg randomised population-based prostate-cancer screening trial.
Yazar:: Hamdy, F
Baskı/Yayın Bilgisi: (2010)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression.
Yazar:: Rouprêt, M, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression
Yazar:: Roupret, M, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
Yazar:: Roupret, M, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer.
Yazar:: Hamdy, F, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Referee
Yazar:: Elisabeth Grobet-Jeandin, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.
Yazar:: Roupret, M, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.
Yazar:: Rouprêt, M, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
Yazar:: Roupret, M, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Understanding and improving recruitment to randomised controlled trials: Qualitative research approaches.
Yazar:: Elliott, D, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Robot-assisted laparoscopic artificial urinary sphincter insertion in women with stress urinary incontinence: A pilot single-center study
Yazar:: E. Chartier-Kastler, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Addressing patient treatment preferences at trial recruitment.
Yazar:: Mills, N, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

THE PROTECT TRIAL - EVALUATING THE EFFECTIVENESS OF TREATMENTS FOR CLINICALLY LOCALISED PROSTATE CANCER
Yazar:: Lane, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

[Early diagnosis and surgical management of prostate cancer]
Yazar:: Linton, D, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Early diagnosis and surgical management of prostate cancer
Yazar:: Linton, D, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
Yazar:: Donovan, J, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
Yazar:: Lane, J, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Exploring treatment preferences facilitated recruitment to randomized controlled trials
Yazar:: Mills, N, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Exploring treatment preferences facilitated recruitment to randomized controlled trials.
Yazar:: Mills, N, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study.
Yazar:: Mills, N, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Clinical Trial Protocol for PERFECT: A Randomised Controlled Trial Comparing the Efficiency and Tolerance of Transperineal Fusion Versus Transrectal Imaging-targeted Prostate Biopsies (CCAFU-PR1 Study)
Yazar:: Alae Touzani, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297)
Yazar:: Lane, J, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

In defense of randomized clinical trials in surgery: Let us not forget Archie Cochrane's legacy.
Yazar:: Catto, J, ve diğerleri
Baskı/Yayın Bilgisi: (2017)